Apioneer in the healthcare industry, J Mitra & Co. was established in 1969 with a vision to serve the society with advanced technology and innovative diagnostic products. Over the years, it has established a firm foothold globally as an eminent manufacturer of in vitro diagnostics (IVD).
Since its inception, the company has been raising the bar of its own set of high-standards by producing stateof-the-art diagnostic test kits and instruments. As a globally acknowledged medical diagnostics company, J Mitra & Co. strictly adheres to the international standards of manufacturing.
SCALING NEW HEIGHTS
Its keenness to serve mankind inspires J Mitra & Co., to improvise its products continuously, which also provides the company an edge over its competitors. The company produces an extensive range of products, including rapid test kits, ELISA test kits, confirmatory test, blood grouping sera, and fluorescence immunoassay test kits.
It has also attained the position of first ever Indian company to receive drug manufacturing licenses for perilous tests, including Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Dengue and Leptospira in rapid and ELISA formats in India.
An indigenous diagnostic brand, J Mitra & Co., has introduced cutting-edge technology for the differential detection of HIV 1 and HIV 2 in a single rapid kit format. Due to its utility, the product has earned an excelling position in the market and is still counted as one of the best after two decades. The group with its highly dedicated professional team has developed numerous import substitute technologies, including diagnostic test kits for the detection of critical diseases such as AIDS (HIV 1 and HIV 2), Hepatitis B, Hepatitis C, malaria, dengue, tuberculosis, and much more.
The diagnostic brand has recently introduced India’s first portable diagnostic solution, iQuant – an avantgarde fluorescence immunoassay analyzer for performing quantitative and qualitative determination of blood test parameters. The instrument has been developed in association with Healthcare Technology Innovation Centre (HTIC), IIT, Madras. The company has also initiated an exclusive range of test parameters that can be performed on this analyser, including thyroid-stimulating hormone (TSH), tri-iodothyronine (T3), thyroxin (T4), Vitamin D, Dengue NS1 antigen and haemoglobin A1c or glycated haemoglobin test that is the National Glycohemoglobin Standardization Program (NGSP) certified.
AWARDS AND RECOGNITION
An internationally acclaimed diagnostic brand, J Mitra & Co. has earned the “Conformité Européenne” (CE) mark for its products. The organisation was conferred award in healthcare at the 7th ‘Global Healthcare Excellence Awards’ 2019 for its exceptional services, innovation, and research in the sector. Through its flawless services, technical support, and huge network, the firm has marked its presence in 40 countries. Working on a no compromising policy in terms of quality of products, it lays great emphasis on safety measures and is consistently registering a harmonious growth.